- $50.05bn
- $30.07bn
- $77.08bn
- 67
- 90
- 59
- 84
Annual balance sheet for Metlife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-Q | 10-K | 10-K | |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Cash and Equivalents | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,210 | — | 3,561 | 3,528 | — |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Deferred Policy Acquisition Costs | |||||
| Total Other Assets | |||||
| Total Assets | 759,708 | 663,072 | 687,584 | 677,457 | — |
| Accrued Expenses | |||||
| Policy Liabilities | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 692,226 | 633,191 | 657,569 | 650,012 | — |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 67,482 | 29,881 | 30,015 | 27,445 | — |
| Total Liabilities & Shareholders' Equity | 759,708 | 663,072 | 687,584 | 677,457 | — |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |